Croda Pharma is a leading partner for developing excipients and supplying high-purity materials for pharmaceutical formulations, offering high-purity excipients that enhance delivery, efficacy and stability of active ingredients, along with high-performing vaccine adjuvants and in-house formulation expertise to navigate drug and vaccine formulation challenges. The company focuses on enabling biologics drug delivery through its adjuvant systems and small molecule, protein and nucleic acid delivery platforms, offering solutions for both human and animal health markets backed by substantial investment in GMP and multi-site EXCiPACT accreditation.

No comments available.
Leave your rating & comment